We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $440M
1-Year Est. Return 28.33%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+28.33%
3 Year Est. Return
+79.73%
5 Year Est. Return
-17.94%
10 Year Est. Return
AUM
$440M
AUM Growth
+$47.5M
Cap. Flow
+$11.1M
Cap. Flow %
2.52%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TMS
Teamshares Inc
TMS
+$11.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.68%
2 Healthcare 6.27%
3 Financials 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$71.2B
$272M 61.76%
3,243,484
VTV icon
2
Vanguard Morningstar Value ETF
VTV
$193B
$113M 25.77%
520,000
INDA icon
3
iShares MSCI India ETF
INDA
$6.75B
$18.3M 4.15%
369,600
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.31B
$10.7M 2.44%
989,410
TMS
5
Teamshares Inc
TMS
$479M
$9.04M 2.06%
+1,099,974
New +$11.1M
FHTX icon
6
Foghorn Therapeutics
FHTX
$291M
$7.68M 1.75%
1,573,761
PMVP icon
7
PMV Pharmaceuticals
PMVP
$69.5M
$3.52M 0.8%
2,627,643
ALEC icon
8
Alector
ALEC
$275M
$2.63M 0.6%
1,307,858
SRZN icon
9
Surrozen
SRZN
$261M
$2.28M 0.52%
87,696
TNYA icon
10
Tenaya Therapeutics
TNYA
$155M
$751K 0.17%
1,015,705
SRZNW
11
DELISTED
Surrozen Inc Warrant
SRZNW
$2.82K ﹤0.01%
170,833

Similar funds

Euclidean Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Euclidean Capital held 11 positions worth $440M, up 12% from $392M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital's Q2 2026 filing shows 1 new position. Its largest new stake was Teamshares Inc: 1,099,974 shares worth $9.04M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Healthcare and Financials.

  • Euclidean Capital's largest Q2 2026 buy was Teamshares Inc: 1,099,974 shares worth $9.04M.
  • Euclidean Capital's ten largest holdings make up 100% of its $440M portfolio in Q2 2026.
  • Euclidean Capital opened 1 new position and closed 0 in Q2 2026.
  • Euclidean Capital's portfolio value rose 12% quarter-over-quarter to $440M.

Based on Euclidean Capital's 13F filing for Q2 2026, filed 14 Aug 2026.